ischemic stroke - Nursing Case Study
Pathophysiology
• Primary mechanism: An ischemic stroke occurs when a blood clot obstructs a cerebral artery, limiting blood flow and oxygen to brain tissue, leading to cell death and loss of neurological function.
• Secondary mechanism: The clot often originates from atherosclerotic plaque rupture or embolism from the heart, commonly due to atrial fibrillation, causing sudden vessel occlusion.
• Key complication: Resulting cerebral ischemia can lead to infarction and edema, increasing intracranial pressure and potentially causing further neuronal injury and functional deficits.
Patient Profile
Demographics:
68-year-old male, retired school teacher
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia
• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Sudden onset of right-sided weakness and difficulty speaking
• Key symptoms: Right-sided hemiparesis, slurred speech, facial droop on the right side, mild headache
• Vital signs: Blood pressure 178/95 mmHg, heart rate 92 bpm, respiratory rate 20 breaths/min, temperature 98.6°F, oxygen saturation 94% on room air
Section 1
As the healthcare team initiates treatment for the ischemic stroke, a sudden change in the patient's status is observed. Approximately 24 hours after admission, the patient begins to exhibit signs of increased intracranial pressure (ICP). He becomes increasingly lethargic and difficult to arouse, with a noticeable decrease in responsiveness to verbal stimuli. His speech becomes more slurred, and his right-sided weakness progresses to complete paralysis. Repeat vital signs reveal a blood pressure of 190/100 mmHg, heart rate of 58 bpm, respiratory rate of 14 breaths/min, and an oxygen saturation of 92% on room air. The bradycardia and elevated blood pressure suggest Cushing's triad, indicative of rising ICP.
A STAT CT scan of the head is performed, revealing significant cerebral edema surrounding the area of infarction in the left hemisphere. The edema is causing a midline shift, exacerbating the patient's neurological deficits. The healthcare team must now consider the implications of this complication and prioritize interventions that could minimize further neuronal injury. Mannitol is administered to reduce cerebral swelling, and the patient is positioned with the head elevated to promote venous drainage. Neurological assessments are conducted frequently to monitor for further deterioration.
This development necessitates a reevaluation of the patient's treatment plan. The team discusses the potential need for surgical intervention, such as a decompressive craniectomy, to alleviate pressure and prevent further herniation. Additionally, the patient's blood pressure management is scrutinized, considering the delicate balance between ensuring cerebral perfusion and preventing exacerbation of edema. This evolving situation requires diligent clinical reasoning to prioritize care and optimize outcomes, as the team works to stabilize the patient and mitigate the risks associated with increased ICP.
Section 2
The patient's response to the initial interventions provides some insight into the evolving clinical picture. After the administration of mannitol, the healthcare team notes a slight improvement in the patient's neurological status. He becomes marginally more responsive, able to open his eyes to loud verbal stimuli and attempts to follow simple commands, although his right-sided paralysis persists. This response suggests a partial reduction in intracranial pressure, but the team remains vigilant, understanding that cerebral edema can fluctuate and rebound if not carefully managed.
Despite these modest improvements, new complications arise. The patient's laboratory results indicate a slight derangement in electrolytes, with a sodium level of 130 mmol/L, indicating hyponatremia, which could further contribute to cerebral edema if not addressed. Additionally, a follow-up CT scan shows that while the midline shift has not worsened, there is still significant edema present, necessitating continued monitoring and intervention. Recognizing the delicate balance required, the medical team decides to initiate hypertonic saline therapy to correct the hyponatremia and further reduce cerebral swelling.
The patient's blood pressure remains elevated, hovering around 185/95 mmHg, despite adjustments in medication aimed at achieving optimal cerebral perfusion without exacerbating the edema. The team deliberates the next steps, weighing the risks and benefits of surgical intervention against conservative management. They decide to consult the neurosurgical team for a potential decompressive craniectomy, understanding that timely surgical intervention might be pivotal in preventing further deterioration. As they await the surgical team's evaluation, the healthcare providers continue to conduct frequent neurological assessments, adjust medications as needed, and support the patient's family, preparing them for the possibility of more invasive procedures. This multifaceted approach underscores the complexity of managing ischemic stroke with complications, demanding ongoing clinical reasoning and adaptive strategies.
Section 3
As the medical team continues to monitor the patient's condition, they observe a significant change in his status. During a routine neurological assessment, the patient exhibits increased confusion and agitation, struggling to follow commands that he previously managed. His pupils are now unequal, with the right pupil dilated and sluggish to react to light, a worrying sign suggestive of rising intracranial pressure. His heart rate has increased to 110 beats per minute, and his respiratory rate has decreased to 10 breaths per minute, indicating potential respiratory compromise. These changes prompt the team to reassess their management strategy urgently.
In response to these alarming signs, the healthcare providers expedite the neurosurgical consultation, as the clinical picture suggests a worsening of cerebral edema with possible herniation risk. Laboratory results show that the sodium level has increased to 145 mmol/L following hypertonic saline administration, which suggests effective correction of hyponatremia. However, the new onset of symptoms indicates that the balance of cerebral perfusion and pressure remains precarious. Continuous monitoring of arterial blood gases reveals a slight respiratory acidosis with a pH of 7.32, further complicating the clinical picture and calling for careful ventilation management to avoid further cerebral compromise.
As the team awaits the neurosurgical team's decision, they intensify their supportive measures, increasing the frequency of neurological checks and adjusting the ventilator settings to optimize oxygenation and carbon dioxide removal. They also initiate prophylactic measures for potential seizures, given the increased risk associated with the fluctuating intracranial dynamics. This stage of the patient's journey highlights the critical need for timely intervention and the importance of maintaining a dynamic approach to treatment, ensuring that each aspect of care is tailored to the evolving clinical status.
Section 4
As the medical team continues to navigate the complexities of the patient's condition, a critical development arises that demands immediate attention. During a subsequent assessment, the patient exhibits a sudden onset of left-sided hemiparesis, which was not present in the initial evaluations. This new finding is accompanied by an increase in systolic blood pressure to 180 mmHg, while diastolic remains elevated at 100 mmHg, suggesting a compensatory response to the increased intracranial pressure. Additionally, the patient's Glasgow Coma Scale (GCS) score has deteriorated from 12 to 9, indicating a concerning decline in consciousness level.
In light of these changes, the team urgently reviews the latest CT scan results, which reveal a marked midline shift and signs of hemorrhagic transformation in the previously ischemic region. This complication significantly alters the management trajectory, as the risk of further neurological deterioration escalates. The decision is made to prepare the patient for possible surgical intervention, such as decompressive craniectomy, to alleviate the pressure and prevent further herniation.
The team also revisits the patient's medication regimen, adjusting dosages to optimize cerebral perfusion and stabilize intracranial dynamics. They initiate a continuous infusion of mannitol, aiming to reduce cerebral edema, while maintaining vigilant monitoring for any adverse effects. The escalation in care underscores the necessity of integrating clinical reasoning with real-time data interpretation, ensuring that interventions remain aligned with the evolving clinical picture. As preparations for surgery proceed, the medical team remains poised to adapt their strategy in response to any further changes in the patient's status, highlighting the dynamic and multifaceted nature of managing ischemic stroke with complications.
Section 5
As the medical team closely monitors the patient following the initiation of mannitol infusion, they observe an initial positive response. The patient’s systolic blood pressure begins to stabilize, decreasing to 160 mmHg, while the diastolic remains at 95 mmHg. This improvement suggests a partial alleviation of intracranial pressure, corroborated by a slight increase in the patient's Glasgow Coma Scale score, which rises to 10. However, the team remains cautious, aware that these changes can be transient and that continuous monitoring is essential.
Despite these encouraging signs, new complications emerge as the patient starts exhibiting symptoms of acute kidney injury, a known side effect of mannitol. Laboratory results indicate a rise in serum creatinine to 2.1 mg/dL from a baseline of 1.0 mg/dL, and a decrease in urine output to 20 mL per hour, raising concerns about the patient's renal function. The team must now balance the need to manage cerebral edema with the risk of exacerbating renal impairment. This scenario requires a careful re-evaluation of the patient's fluid status and consideration for alternative interventions or dose adjustments.
The nephrology team is consulted to provide expertise in managing the renal complications, and together with the neurology team, they deliberate on modifying the therapeutic approach. Options such as reducing the dose of mannitol or switching to hypertonic saline are discussed, emphasizing the necessity of tailored interventions based on the evolving clinical picture. Meanwhile, preparations for potential surgical intervention proceed, as the medical team remains vigilant, ready to respond to any further shifts in the patient's condition. This ongoing interdisciplinary collaboration underscores the complexity of the case and the need for dynamic, evidence-based decision-making.